Graham Ogg Selected Research

Graham Ogg Research Topics

Disease

8	Infections 01/2022 - 01/2011
8	COVID-19 01/2022 - 01/2020
6	Atopic Dermatitis (Atopic Eczema) 01/2022 - 02/2016
6	Inflammation (Inflammations) 01/2022 - 01/2012
5	Neoplasms (Cancer) 12/2022 - 04/2002
4	Hypersensitivity (Allergy) 01/2022 - 01/2016
4	Asthma (Bronchial Asthma) 07/2021 - 05/2015
4	Skin Diseases (Skin Disease) 01/2021 - 02/2015
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 10/2016
2	Chronic Urticaria 01/2022 - 01/2021
2	Human Influenza (Influenza) 01/2021 - 01/2014
2	Communicable Diseases (Infectious Diseases) 10/2009 - 01/2007
2	Lymphoma (Lymphomas) 01/2007 - 04/2002
1	Glioblastoma (Glioblastoma Multiforme) 12/2022
1	Testicular Neoplasms (Testicular Cancer) 12/2022
1	Disease Progression 01/2022
1	Critical Illness (Critically Ill) 01/2021
1	Urticaria (Hives) 01/2021
1	Pruritus (Itching) 01/2021
1	Cytokine Release Syndrome 01/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Dermatitis 10/2019
1	Eosinophilia 01/2018
1	Venom Hypersensitivity 01/2016
1	Herpes Zoster 02/2013
1	Chickenpox 02/2013
1	Multiple Sclerosis 09/2011
1	Autoimmune Diseases (Autoimmune Disease) 09/2011
1	Immune Reconstitution Inflammatory Syndrome 09/2011
1	Encephalitis (Encephalitis, Rasmussen) 09/2011
1	Dengue (Dengue Fever) 01/2011
1	Shock 01/2011
1	Severe Dengue 01/2011
1	Neoplasm Metastasis (Metastasis) 01/2007
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2004
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2004
1	Wilms Tumor (Wilm's Tumor) 06/2004
1	Leukemia 06/2004

Drug/Important Bio-Agent (IBA)

11	AntigensIBA 12/2022 - 06/2004
10	Peptides (Polypeptides)IBA 01/2022 - 04/2002
7	LipidsIBA 01/2022 - 10/2016
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2002
4	Biological ProductsIBA 01/2022 - 01/2021
4	CytokinesIBA 07/2021 - 01/2018
4	VaccinesIBA 06/2020 - 01/2007
3	Phospholipases (Phospholipase)IBA 01/2022 - 02/2015
3	Filaggrin ProteinsIBA 01/2022 - 02/2016
2	Interleukin-22 (IL-22)IBA 01/2022 - 10/2019
2	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2021
2	Omalizumab (Xolair)FDA Link 01/2022 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 07/2021 - 01/2020
2	dupilumabIBA 01/2021 - 01/2021
2	InterferonsIBA 11/2020 - 09/2011
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 06/2020 - 01/2011
2	ChemokinesIBA 01/2020 - 01/2018
2	Monoclonal AntibodiesIBA 10/2019 - 09/2011
2	Interleukin-4 (Interleukin 4)IBA 10/2019 - 09/2011
1	Decitabine FDA Link 12/2022
1	acyloxyacyl hydrolaseIBA 01/2022
1	LigandsIBA 01/2022
1	Lipase (Acid Lipase)FDA Link 01/2022
1	NickelIBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Interleukin-8 (Interleukin 8)IBA 07/2021
1	Blood Proteins (Serum Proteins)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	Viral AntigensIBA 01/2021
1	Immunodominant EpitopesIBA 06/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020
1	Chemokine CCL5IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Immunoglobulin G (IgG)IBA 10/2019
1	Interleukin-33IBA 10/2019
1	Interleukin-9 (Interleukin 9)IBA 10/2019
1	Interleukin-17 (Interleukin 17)IBA 10/2019
1	InflammasomesIBA 10/2019
1	Interleukin-13IBA 10/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2019
1	Interleukin-5 (Interleukin 5)IBA 10/2019
1	Thymic Stromal LymphopoietinIBA 12/2017
1	HaptensIBA 02/2016
1	Wasp Venoms (Venom, Wasp)IBA 01/2016
1	VenomsIBA 01/2016
1	Prostaglandin D2IBA 05/2015
1	Leukotriene E4IBA 05/2015
1	EmulsionsIBA 01/2014
1	HLA-A*02:01 antigenIBA 01/2014
1	Prostaglandins DIBA 01/2012
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2012
1	AntibodiesIBA 09/2011
1	Natalizumab (Tysabri)FDA Link 09/2011
1	EpitopesIBA 01/2011
1	HLA-A31 antigenIBA 01/2011
1	OvalbuminIBA 01/2007

Therapy/Procedure

4	Therapeutics 06/2020 - 04/2002
3	Immunotherapy 12/2022 - 10/2009
1	Length of Stay 07/2021
1	Transplantation 06/2004